Cypress Capital Management (Wyoming)’s Collegium Pharmaceutical COLL Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$234K	Buy	+7,080	New	+$300K	0.22%	48

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s COLL Position: Q1 2026 in Review

Cypress Capital Management (Wyoming) opened a new position in Collegium Pharmaceutical (COLL) in Q1 2026: 7,080 shares worth $234K. The stake represents 0.22% of the portfolio and ranks #48 among its holdings.

266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Cypress Capital Management (Wyoming) held 7,080 shares of Collegium Pharmaceutical worth $234K as of Q1 2026.
Collegium Pharmaceutical was a new Cypress Capital Management (Wyoming) position in Q1 2026.
Collegium Pharmaceutical made up 0.22% of Cypress Capital Management (Wyoming)'s portfolio in Q1 2026, its #48 holding.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2026, filed 8 May 2026.